P.KumarA.DwivediS.DeebaF.KumarS.et al (2015a)
Glycemic control, weight management, cardiovascular safety, and cost-effectiveness of semaglutide for patients with type 2 diabetes mellitus: a rapid review and meta-analysis of real-world studies
Zero retention at that same timepoint
The study results, published in the July 15, 2026, online edition of The Lancet Gastroenterology & Hepatology , address a major unmet need for people with metabolic dysfunctionassociated steatohepatitis (MASH), a serious form of fatty liver disease that can lead to cirrhosis, liver failure, and the need for transplantation
The lower dose weekly has allowed me to loose 43 pounds since the first week in November 2024
This article explores the benefits, risks, and what you should expect from this treatment